If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

Share Price is delayed by 15 minutes
Get Live Data
70.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.30 (0.428%)
Market Cap: £671.89m
DOCS Live PriceLast checked at - London Stock Exchange

Intraday Dr. Martens Share Chart

Result of 2025 AGM

10 Jul 2025 10:58

RNS Number : 5713Q
Dr. Martens PLC
10 July 2025
 

10 July 2025

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

10 JULY 2025

 

The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.

Resolutions 1 to 18 were proposed as Ordinary Resolutions and resolutions 19 to 22 as Special Resolutions.

Resolution

 

 

 

VotesFor

(note 1)

 

%

 

 

Votes Against

(note 1)

 

%

 

 

VotesTotal

 

 

Votes Withheld

(note 2)

% Voting

Capital Instructed

01

Receive the 2025 Annual Report and Accounts

786,076,243

100.00

34,102

0.00

786,110,345

370,385

81.35%

02

Approve the Directors' Remuneration Report

782,786,026

99.59

3,213,373

0.41

785,999,399

475,436

81.34%

03

Approve the Final Dividend

786,441,111

100.00

32,729

0.00

786,473,840

6,890

81.39%

04

Elect Ije Nwokorie

711,638,324

90.49

74,812,462

9.51

786,450,786

24,049

81.38%

05

Elect Benoit Vauchy

710,606,698

90.36

75,837,289

9.64

786,443,987

30,848

81.38%

06

Elect Robert Hanson

786,302,310

99.98

134,818

0.02

786,437,128

37,707

81.38%

07

Re-elect Giles Wilson

711,569,954

90.49

74,821,751

9.51

786,391,705

83,130

81.38%

08

Re-elect Lynne Weedall

777,807,755

98.90

8,621,954

1.10

786,429,709

45,126

81.38%

09

Re-elect Robyn Perriss

782,666,553

99.52

3,762,111

0.48

786,428,664

46,171

81.38%

10

Re-elect Andrew Harrison

782,674,150

99.52

3,768,078

0.48

786,442,228

32,607

81.38%

11

Re-elect Ian Rogers

781,923,703

99.43

4,518,525

0.57

786,442,228

32,607

81.38%

12

Re-elect Paul Mason

659,171,361

88.07

89,279,024

11.93

748,450,385

38,024,450

77.45%

13

Re-elect Tara Alhadeff

700,151,020

89.26

84,277,826

10.74

784,428,846

2,045,989

81.18%

14

Re-appoint PricewaterhouseCoopers LLP as auditor

786,339,031

99.99

54,271

0.01

786,393,302

81,533

81.38%

15

Authorise the Audit & Risk Committee to determine the Auditor's remuneration

786,364,884

99.99

43,453

0.01

786,408,337

66,498

81.38%

16

Approve the removal of the 5% dilution limit for discretionary share plans

785,386,811

99.87

1,055,301

0.13

786,442,112

38,618

81.38%

17

Authorise the Company and its subsidiaries to make political donations

785,724,771

99.92

665,753

0.08

786,390,524

90,206

81.38%

18

Authorise allotment of shares

783,312,171

99.62

2,997,814

0.38

786,309,985

170,745

81.37%

19

Authorise general disapplication of pre-emption rights*

745,894,239

94.86

40,453,577

5.14

786,347,816

127,019

81.37%

20

Authorise additional disapplication of pre-emption rights*

745,011,084

94.74

41,380,015

5.26

786,391,099

83,736

81.38%

21

Authorise purchase of own shares*

771,750,586

98.19

14,255,925

1.81

786,006,511

474,219

81.34%

22

Authorise calling of general meetings on 14 days' notice*

782,554,288

99.51

3,857,228

0.49

786,411,516

63,319

81.38%

*Special Resolution

 

The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:

Resolution

 

 

VotesFor

 

%

 

Votes Against

 

%

 

VotesTotal

 

Votes Withheld

 

% Independent

Capital Instructed

06

Elect Robert Hanson

416,359,870

99.97

134,818

0.03

416,494,688

37,707

69.83%

08

Re-elect Lynne Weedall

407,865,315

97.93

8,621,954

2.07

416,487,269

45,126

69.83%

09

Re-elect Robyn Perriss

412,724,113

99.10

3,762,111

0.90

416,486,224

46,171

69.83%

10

Re-elect Andrew Harrison

412,731,710

99.10

3,768,078

0.90

416,499,788

32,607

69.84%

11

Re-elect Ian Rogers

411,981,263

98.92

4,518,525

1.08

416,499,788

32,607

69.84%

 

Notes:

1. Votes "For" and "Against" are expressed as a percentage of votes received.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

3. As at 6.30pm on 9 July 2025 the Company had a total of 966,341,901 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 6 and 8 to 11, was 596,399,461.

4. In accordance with Listing Rule 6.4.2(R), copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Enquiries

Company Secretariat

Paul Rolling, Head of Secretariat +44 7584 243562

 

 

Investors and analysts

Bethany Barnes, Director of Investor Relations +44 7825 187465

bethany.barnes@drmartens.com

Beth Fionda, Investor Relations Manager beth.fionda@drmartens.com

 

Press

Sodali & Co

Ludo Baynham-Herd

Oliver Banks drmartens@client.sodali.com

+44 207 250 1446

 

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. "Docs" or "DMs" were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over 60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and wholesale channels, and in addition to its world-renowned "1460" boot its product segments span shoes including the 1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and accessories. Further information can be found at https://www.drmartensplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFLSUSEISEIW
Date   Source Headline
2nd Oct 20257:00 amRNS-RUAE distribution partnership and LATAM expansion
16th Sep 202511:55 amRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSHolding(s) in Company
2nd Sep 20259:30 amRNSDirector/PCA Shareholding
29th Aug 20254:22 pmRNSTotal Voting Rights
12th Aug 20253:17 pmRNSDirector/PDMR Shareholding
1st Aug 202511:51 amRNSTotal Voting Rights
28th Jul 20258:53 amRNSDirector/PDMR Shareholding
14th Jul 20253:08 pmRNSDirector/PDMR Shareholding
10th Jul 202510:58 amRNSResult of 2025 AGM
10th Jul 20257:00 amRNSAGM Trading Update
4th Jul 20251:56 pmRNSTotal Voting Rights
17th Jun 202510:00 amRNSDirector/PDMR Shareholding
17th Jun 20259:00 amRNSAnnual Financial Report
12th Jun 20254:13 pmRNSDirector/PDMR Shareholding
5th Jun 20257:00 amRNSFinal Results
2nd Jun 20252:05 pmRNSBlock listing Interim Review
30th May 202510:52 amRNSTotal Voting Rights
27th May 20258:45 amRNSDirector Declaration
14th May 20252:20 pmRNSDirector/PDMR Shareholding
1st May 20254:02 pmRNSTotal Voting Rights
16th Apr 20254:00 pmRNSDirector/PDMR Shareholding
9th Apr 20253:00 pmRNSDirector/PDMR Shareholding
31st Mar 20259:38 amRNSTotal Voting Rights
26th Mar 202510:00 amRNSDirector/PDMR Shareholding
12th Mar 20252:26 pmRNSDirector/PDMR Shareholding
28th Feb 202511:01 amRNSTotal Voting Rights
12th Feb 20254:35 pmRNSDirector/PDMR Shareholding
12th Feb 20257:00 amRNSAppointment of Non-Executive Directors
31st Jan 202510:36 amRNSTotal Voting Rights
27th Jan 20257:00 amRNSQ3 FY25 Trading Statement
15th Jan 20256:14 pmRNSDirector/PDMR Shareholding
2nd Jan 202512:02 pmRNSTotal Voting Rights
20th Dec 20243:07 pmRNSHolding(s) in Company
13th Dec 202411:54 amRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSBlock Listing Application
2nd Dec 202410:43 amRNSBlock listing Interim Review
2nd Dec 202410:10 amRNSTotal Voting Rights
28th Nov 20247:01 amRNSConfirmation of new CEO start date
28th Nov 20247:00 amRNSHalf-year Report
12th Nov 20243:56 pmRNSDirector/PDMR Shareholding
31st Oct 20243:23 pmRNSTotal Voting Rights
15th Oct 20243:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20241:55 pmRNSDirector/PDMR Shareholding
30th Sep 202410:24 amRNSTotal Voting Rights
26th Sep 20242:00 pmRNSTransaction by PCA of PDMR
25th Sep 20247:00 amRNSHolding(s) in Company
24th Sep 202410:53 amRNSDirector/PDMR Shareholding
23rd Sep 20244:31 pmRNSHolding(s) in Company
12th Sep 20243:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.